OBJECTIVES: The aim of this study was to determine whether a normal stress-only single-photon emission computed tomographic myocardial perfusion tomography (SPECT) study confers the same prognosis as a normal SPECT on the basis of evaluation of stress and rest images. BACKGROUND: Current guidelines recommend stress and rest imaging to confirm that a SPECT study is normal. METHODS: We determined all-cause mortality in 16,854 consecutive patients who had a normal gated stress SPECT. Median follow-up was 4.5 years. A stress-only protocol was used in 8,034 patients (47.6%), whereas 8,820 (52.4%) had both stress and rest imaging. RESULTS: The overall unadjusted annual mortality rate in patients who had a normal SPECT with a stress-only protocol was lower than in those who required additional rest imaging (2.57% vs. 2.92%, p = 0.02). After adjustment for baseline clinical characteristics no significant differences in patient mortality were seen between the 2 imaging protocols, but the stress-only group received a 61% lower radiopharmaceutical dosage. Independent predictors of worse survival included increasing age, male sex, diabetes, history of coronary artery disease, and inability to exercise (all p < 0.001) but not the type of SPECT protocol used to image patients. CONCLUSIONS: Patients determined to have a normal SPECT on the basis of stress imaging alone have a similar mortality rate as those who have a normal SPECT on the basis of evaluation of both stress and rest images. Our results support that additional rest imaging is not required in patients who have a normally appearing initial stress study. A significant reduction in radiation exposure can be achieved with such an approach. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
OBJECTIVES: The aim of this study was to determine whether a normal stress-only single-photon emission computed tomographic myocardial perfusion tomography (SPECT) study confers the same prognosis as a normal SPECT on the basis of evaluation of stress and rest images. BACKGROUND: Current guidelines recommend stress and rest imaging to confirm that a SPECT study is normal. METHODS: We determined all-cause mortality in 16,854 consecutive patients who had a normal gated stress SPECT. Median follow-up was 4.5 years. A stress-only protocol was used in 8,034 patients (47.6%), whereas 8,820 (52.4%) had both stress and rest imaging. RESULTS: The overall unadjusted annual mortality rate in patients who had a normal SPECT with a stress-only protocol was lower than in those who required additional rest imaging (2.57% vs. 2.92%, p = 0.02). After adjustment for baseline clinical characteristics no significant differences in patient mortality were seen between the 2 imaging protocols, but the stress-only group received a 61% lower radiopharmaceutical dosage. Independent predictors of worse survival included increasing age, male sex, diabetes, history of coronary artery disease, and inability to exercise (all p < 0.001) but not the type of SPECT protocol used to image patients. CONCLUSIONS:Patients determined to have a normal SPECT on the basis of stress imaging alone have a similar mortality rate as those who have a normal SPECT on the basis of evaluation of both stress and rest images. Our results support that additional rest imaging is not required in patients who have a normally appearing initial stress study. A significant reduction in radiation exposure can be achieved with such an approach. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Authors: W Lane Duvall; John A Savino; Elliot J Levine; Luke K Hermann; Lori B Croft; Milena J Henzlova Journal: Eur J Nucl Med Mol Imaging Date: 2014-11-04 Impact factor: 9.236
Authors: John J Ryan; Rupa Mehta; Thejasvi Thiruvoipati; R Parker Ward; Kim Allan Williams Journal: J Nucl Cardiol Date: 2012-01-19 Impact factor: 5.952
Authors: E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann Journal: J Nucl Cardiol Date: 2012-04 Impact factor: 5.952
Authors: Manuel D Cerqueira; Kevin C Allman; Edward P Ficaro; Christopher L Hansen; Kenneth J Nichols; Randall C Thompson; William A Van Decker; Marko Yakovlevitch Journal: J Nucl Cardiol Date: 2010-08 Impact factor: 5.952
Authors: Thomas A Holly; Brian G Abbott; Mouaz Al-Mallah; Dennis A Calnon; Mylan C Cohen; Frank P DiFilippo; Edward P Ficaro; Michael R Freeman; Robert C Hendel; Diwakar Jain; Scott M Leonard; Kenneth J Nichols; Donna M Polk; Prem Soman Journal: J Nucl Cardiol Date: 2010-10 Impact factor: 5.952
Authors: Ryo Nakazato; Daniel S Berman; Sean W Hayes; Mathews Fish; Richard Padgett; Yuan Xu; Mark Lemley; Rafael Baavour; Nathaniel Roth; Piotr J Slomka Journal: J Nucl Med Date: 2013-01-15 Impact factor: 10.057